Letter to the Editor
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Oct 6, 2024; 12(28): 6237-6240
Published online Oct 6, 2024. doi: 10.12998/wjcc.v12.i28.6237
Re-evaluating the necessity of routine laboratory monitoring during isotretinoin therapy for acne
Yun-Xia Zhu, Liang Wu, Sheng-Cai Zhu, Xiu-Ping Wang, Deng Zhang, Yan-Ping Tan, Xiao-Liang Ouyang, Chun-Ming Li
Yun-Xia Zhu, Liang Wu, Sheng-Cai Zhu, Xiu-Ping Wang, Deng Zhang, Chun-Ming Li, Department of Dermatology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi Province, China
Yan-Ping Tan, Department of Dermatology, Jiangxi Provincial Maternal and Child Health Hospital, Nanchang 330000, Jiangxi Province, China
Xiao-Liang Ouyang, Department of Plastic Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi Province, China
Co-corresponding authors: Xiao-Liang Ouyang and Chun-Ming Li.
Author contributions: Zhu YX participated in data collection and manuscript writing; Wu L and Zhu SC contributed to data analysis; Wang XP, Zhang D, and Tan YP contributed to conceptualization and supervision; Ouyang XL contributed to conceptualization and supervision; Li CM contributed to manuscript polishing and editing; all authors have read and approved the final manuscript. Both Ouyang XL and Li CM have played important and indispensable roles in the writing and editing of the manuscript and review of the literature as the co-corresponding authors. Ouyang XL conceptualized and supervised the whole process of the project. He searched the literature, and revised and submitted the early version of the manuscript. Li CM was instrumental and responsible for polishing, editing, and submission of the current version of the manuscript.
Conflict-of-interest statement: All authors declare that they have no conflict of interest to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Chun-Ming Li, PhD, Associate Chief Physician, Department of Dermatology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, No. 1 Minde Road, Nanchang 330006, Jiangxi Province, China. chunminglincu@163.com
Received: April 25, 2024
Revised: July 23, 2024
Accepted: August 2, 2024
Published online: October 6, 2024
Processing time: 109 Days and 15.7 Hours
Core Tip

Core Tip: In this letter we comment on the article Park et al. Currently, there is a lack of consensus of the frequency of follow-up of laboratory parameters during isotretinoin treatment. This letter will provide insight into this complex and controversial topic.